GAFFX
Price
$88.06
Change
+$0.17 (+0.19%)
Updated
Oct 17 closing price
Net Assets
336.91B
JLGPX
Price
$89.59
Change
+$0.17 (+0.19%)
Updated
Oct 17 closing price
Net Assets
124.32B
Interact to see
Advertisement

GAFFX vs JLGPX

Header iconGAFFX vs JLGPX Comparison
Open Charts GAFFX vs JLGPXBanner chart's image
American Funds Growth Fund of Amer F3
Price$88.06
Change+$0.17 (+0.19%)
VolumeN/A
Net Assets336.91B
JPMorgan Large Cap Growth R3
Price$89.59
Change+$0.17 (+0.19%)
VolumeN/A
Net Assets124.32B
GAFFX vs JLGPX Comparison Chart in %
View a ticker or compare two or three
VS
GAFFX vs. JLGPX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Hold and JLGPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 337B vs. JLGPX (124B). GAFFX pays higher dividends than JLGPX: GAFFX (0.58) vs JLGPX (0.00). GAFFX was incepted earlier than JLGPX: GAFFX (9 years) vs JLGPX (9 years). JLGPX (1.00) is less costly to investors than GAFFX (0.30). JLGPX is a more actively managed with annual turnover of: 52.00 vs. GAFFX (25.00). JLGPX has a lower initial minimum investment than GAFFX: JLGPX (0) vs GAFFX (1000000). JLGPX annual gain was more profitable for investors over the last year : 17.60 vs. GAFFX (11.99). JLGPX return over 5 years is better than : 53.30 vs. GAFFX (41.86).
GAFFXJLGPXGAFFX / JLGPX
Total Expense Ratio0.300.9432%
Annual Report Gross Expense Ratio0.301.0030%
Fund Existence9 years9 years-
Gain YTD18.24915.051121%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets337B124B272%
Annual Yield % from dividends0.580.00-
Returns for 1 year11.9917.6068%
Returns for 3 years73.6399.4274%
Returns for 5 years41.8653.3079%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERA31.230.72
+2.36%
Vera Therapeutics
SFWL0.950.02
+1.72%
Shengfeng Development Limited
KELYA12.280.02
+0.16%
Kelly Services
DRMA3.97-0.02
-0.50%
Dermata Therapeutics Inc
BILI27.05-0.24
-0.88%
Bilibili